San Mateo, CA, United States of America

Corey M Reeves

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Corey M Reeves: Innovator in ERK Inhibitors and Immune Modulation

Introduction

Corey M Reeves is a notable inventor based in San Mateo, California. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific pathways in immune response and inflammation. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Corey M Reeves holds two recent patents that showcase her innovative research. The first patent, titled "ERK inhibitors and uses thereof," provides compounds and compositions that inhibit ERK1, ERK2, or both, along with methods for their application. The second patent, "Ascaroside derivatives and methods of use," relates to treating immune disorders and inflammation using specific modulator compounds. This invention outlines methods for administering a composition that includes a compound with a defined structure to address immune and inflammatory disorders.

Career Highlights

Throughout her career, Corey has worked with prestigious organizations, including the California Institute of Technology and Holoclara, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Corey M Reeves has collaborated with notable colleagues such as Brian M Stoltz and Eduardo J Martinez. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Corey M Reeves is a distinguished inventor whose work in ERK inhibitors and immune modulation is making a significant impact in the field of biochemistry. Her innovative patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…